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Background: Phobic disorders are highly prevalent and constitute a considerable burden for patients and society.
As patients wait for face-to-face psychotherapy for phobic disorders in outpatient clinics, this time can be used for
guided self-help interventions. The aim of this study is to investigate a five week internet-based guided self-help
programme of exposure therapy in terms of clinical effectiveness and impact on speed of recovery in psychiatric
outpatients, as well as the cost-effectiveness of this pre-treatment waiting list intervention.
Methods/design: A randomised controlled trial will be conducted among 244 Dutch adult patients recruited from
waiting lists of outpatient clinics for face-to-face psychotherapy for phobic disorders. Patients suffering from at least
one DSM-IV classified phobic disorder (social phobia, agoraphobia or specific phobia) are randomly allocated (at a
1:1 ratio) to either a five-week internet-based guided self-help program followed by face-to-face psychotherapy, or
a control group followed by face-to-face psychotherapy. Waiting list status and duration are unchanged and actual
need for further treatment is evaluated prior to face-to-face psychotherapy. Clinical and economic self-assessment
measurements take place at baseline, post-test (five weeks after baseline) and at 3, 6, 9 and 12 months after
baseline.
Discussion: Offering pre-treatment internet-based guided self-help efficiently uses time otherwise lost on a waiting
list and may increase patient satisfaction. Patients are expected to need fewer face-to-face sessions, reducing total
treatment cost and increasing speed of recovery. Internet-delivered treatment for phobias may be a valuable
addition to psychotherapy as demand for outpatient treatment increases while budgets decrease.
Trial registration: Netherlands Trial Register NTR2233
Keywords: Phobias, Phobic disorders, Web-based intervention, Internet therapy, Randomised controlled trial,
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Anxiety disorders have a pooled lifetime prevalence of
19.8% [1]. This makes these disorders the most prevalent
mental disorders for women, and the second most
prevalent for men. Specific phobias are the most com-
mon form of anxiety disorders for both genders, with a* Correspondence: r.n.kok@vu.nl
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reproduction in any medium, provided the ortotal 12-month prevalence of 7.1%, followed by social
phobia (4.8%) and agoraphobia without panic disorder
(1.2%). Phobias are characterised by an excessive fear of
situations or objects and are often treated by gradual ex-
posure to the fear-inducing stimulus and/or cognitive
behavioural therapy.
The economic burden of these conditions is consider-
able [2], as is the negative impact on quality of life and
psychosocial functioning [3], especially if the patient is
often confronted with the fear-inducing situation or ob-
ject in life. In clinical populations this burden may have. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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being, as research suggests that often more than a dec-
ade passes between onset of symptoms and first therapy
attendance [4]. The prevalence and burden of phobic
disorders call for effective and cost-effective treatment
options and the Internet offers an accessible and wide-
spread platform to disseminate low-threshold treatment
for phobias.
Research has shown that guided self-help is effective
for anxiety disorders [5] and that it can be as effective as
face-to-face (FTF) psychotherapy [6]. Self-help programs
adapted for the Internet have shown similar results [7,8],
e.g. for social anxiety disorder [9], generalised anxiety
disorder [10] and severe health anxiety [11]. The use of
internet interventions for treating anxiety disorders has
been well-established and deemed useful and acceptable
in primary care and the general population [12]. A re-
cent small scale study found a large effect size of
internet-based treatment for panic disorder in a psychi-
atric outpatient setting [13] and internet-based cognitive
behavioural therapy (CBT) for adolescent anxiety
appeared to be as efficacious as clinic-based FTF psycho-
therapy [14]. Apart from these studies, little is known
about the clinical effectiveness or cost-effectiveness of
internet-based CBT in psychiatric outpatient settings.
Few studies have examined internet-based treatment of
phobias in particular and these tended to focus on social
phobia in the general population or primary care
patients.
Waiting lists of varying lengths are ubiquitous in psy-
chiatric outpatient clinics. As demand for psychotherapy
often exceeds supply, patients cannot be treated immedi-
ately. Time otherwise ‘lost’ while a patient is on a waiting
list could be spent more efficiently when a waiting list
guided self-help intervention is offered that comprises
elements common in FTF psychotherapy for phobias,
e.g. psychoeducation, goal setting and exposure exercises.
Offering patients a self-help intervention while on a
waiting list for FTF treatment can be advantageous to
both outpatient clinics and patients for several reasons.
Firstly, following the stepped-care model, the inter-
vention may be sufficient treatment for some phobic
disorders, cancelling the need for further psychotherapy
and preventing inappropriate use of outpatient resources.
Secondly, being placed on a waiting list may be disap-
pointing to patients who have been suffering from a
phobia for a long time. This disappointment may lead to
pre-treatment attrition, i.e., patients not starting FTF
psychotherapy or 'no-show'. This has been shown to be
relatively high in FTF settings, up to 30% in social pho-
bia [15]. Offering the intervention during the waiting
period offers a mutual benefit of keeping the patient ac-
tively engaged in his or her treatment and thus possibly
reducing this pre-treatment attrition.Thirdly, depending on the uptake and effects of the
guided self-help intervention, fewer FTF psychotherapy
sessions might suffice when the waiting period has
ended and FTF treatment is scheduled, thus lowering
the pressure on psychiatric outpatient clinics. This can
also lead to lower per-patient treatment costs.
As healthcare budgets stagnate or decline and demand
for treatment for phobias increases, a larger number of
patients will need to be treated at lower costs per
patient.
Aims and hypotheses
The objective of this study is to establish the clinical and
cost-effectiveness of an internet-based brief guided self-
help intervention for phobic patients in outpatient
clinics. We expect that patients are more satisfied as
they can start treatment while on a waiting list and that
outpatient clinics can reduce the number of costly FTF
psychotherapy sessions due to the skills and knowledge
already acquired by the patient in the guided self-help
intervention. Furthermore, we expect that patients in




This study is a randomised controlled trial alongside an
economic evaluation. Patients on a waiting list for FTF
psychotherapy are randomised to either the intervention
group, who will receive access to the internet-based
guided self-help program, or the control group who will
receive a self-help book for motivational purposes with-
out additional guidance. Both groups will receive FTF
psychotherapy at the outpatient clinic following the
guided self-help or unguided motivational book.
The study protocol, information brochure, question-
naires and informed consent form were approved by the
Medical Ethics Committee of the VU University Medical
Centre (registration number 2010/77).
Inclusion and exclusion criteria
All patients aged 18 and over on the waiting list of par-
ticipating outpatient clinics and willing to enrol in an
internet-based self-help program are eligible for this
study. Inclusion criteria are: suffering from a DSM-IV
diagnosis of agoraphobia, social phobia or specific pho-
bia as determined by a trained interviewer using a diag-
nostic interview (the Composite International Diagnostic
Interview (CIDI) [16]). Patients are allowed to continue
their psychotropic medication if they stay on a stable
regimen throughout the intervention. Exclusion criteria
are: no access to the internet, inadequate self-reported
computer literacy, inadequate proficiency in Dutch, sui-
cidal ideation or increased risk of suicide and bipolar or
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lar or psychotic disorders are allowed.Recruitment
Patients are recruited at several outpatient clinics. For
practical reasons, only clinics with a high number of
monthly enrolments were selected. Generally speaking,
patients are referred to the outpatient clinic by their
general practitioner (GP). At the clinic the patient is
briefly screened and placed on a waiting list. After some
time an initial meeting with a therapist takes place, dur-
ing which the patient’s treatment needs and preferences
are determined in detail. Based on this, a treatment sui-
ted to the individual patient is selected, e.g. group CBT
therapy for social anxiety disorders or individual
exposure-based therapy for specific phobias. The
researchers are not involved in this decision process. De-
pending on therapist workload, treatment modality and
other factors, there is considerable variability in the
length of the interval between referral to the clinic and
first therapeutic contact. This interval typically ranges














intervention or control group
Figure 1 Trial flowchart.For this study, patients are recruited when placed on
the post-screening waiting list of outpatient clinics.
Patients agreeing to be contacted by the researchers are
approached by the researchers and a telephone diagnos-
tic interview (CIDI) is conducted by a research assistant
to determine clinical status. If eligible, the patients are
administered a telephone baseline assessment and ran-
domised. Patients are sent an information kit containing
a study brochure, informed consent form and stamped
return envelope. The first therapeutic contact (i.e., first
meeting with therapist to determine patient’s status and
needs) is not postponed if the patient is enrolled in this
study. For a detailed representation of participant flow
in this study, see Figure 1.Randomisation
After baseline assessment patients are randomised by an
external researcher using a computer-generated random-
isation chart which is stratified by clinic. Block random-
isation is used with eight allocations per block, using a
1:1 ratio. Researchers are blind to the randomisation
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nature of the intervention, patients cannot be blinded to
group allocation as the two treatment options need to
be revealed prior to randomisation.
Intervention: internet-based guided self-help exposure
therapy
The intervention is adapted for the internet from a self-
help book on phobias [17], which is based on exposure
therapy, the de facto standard treatment in phobic anx-
iety disorders. The internet treatment is offered at no
cost to the patient, takes five weeks to complete and is
based on psycho-education and exposure therapy with
optional though schedules. Patients select fear-inducing
situations or stimuli and construct a ‘fear hierarchy’ to
increasingly expose themselves to these situations or
stimuli in gradual, ascending steps. Background informa-
tion and psychoeducation on phobias is given, as well as
information on relapse prevention, recommendations
and gathering support from friends. A number of ex-
ample patients are included to illustrate the principles
and concepts of the intervention. Support consists of on-
line coaching messages, delivered through a closed,
secured message system on the intervention website.
This is offered by master’s level students of clinical
psychology who have received training in online coaching.
Research has shown that relatively inexperienced persons
can provide effective online coaching on a level equal to
an experience clinician, if they are adequately trained,
supervised and the treatment is sufficiently standardized
and manualized [18,19]. The patient completes exposure
exercises as homework assignments and reports on his or
her accomplishments each week. The coach monitors the
fear hierarchy and evaluates whether the patient’s expos-
ure exercise planning is feasible, relevant and useful and
replies with a support message with praise, recommenda-
tions and information relevant to the patient’s homework
accomplishments or experiences.
The intervention is tunnelled, i.e., no new material is
available to the patient until the patient has reported on
that week’s achievements and the coach has provided
feedback on these achievements. If applicable, the coach
sends a standardized reminder message if the patient did
not use the website that week. Material from previous
weeks remains accessible to the patient. To allow for any
technical difficulties, patients are allowed to overrun the
five-week intervention by one week.
All coaching will be supervised by an experienced psy-
chotherapist (MdN), who is trained in in-vivo exposure
therapy. We will keep close contact with the institutions
and therapists and carefully monitor each patient, send-
ing the therapist an informative reminder message of the
patient’s participation in the study immediately before
first therapeutic contact. This is to encourage thetherapist to assess the patient’s condition first and, if
deemed necessary, to adjust therapeutic approach and
aims to suit the patient’s prior knowledge and previous
exposure accomplishments attained during the
intervention.
Control group
The control group will receive a self-help book [17] free
of charge, without additional support. This self-help
book contains the same information as the intervention
website, i.e., psycho-education and exposure therapy, but
has more optional exercises such as thought schedules.
It was deemed unethical to enrol patients into the trial
and subsequently allocate them to a control condition
without offering at least some compensation for their
time and effort. The book is sent as-is, without further
instructions or expectations, as unguided bibliotherapy.
The patients will have no contact with the research team
with regards to the self-help book during or after the
self-help period.
Psychotherapy
Patients in both the intervention group and the control
group are scheduled to receive follow-up FTF psycho-
therapy by licensed health care psychologists at the end
of the waiting list but patients can choose to decline fur-
ther FTF treatment.
Assessments
In total, 6 assessments will take place. The baseline as-
sessment takes place before randomisation, with follow-
up assessments post-intervention (at five weeks), and at
3, 6, 9 and 12 months. Baseline measures are collected
by telephone to ensure pre-treatment assessments are
present for all patients and follow-up measures are
administered as online questionnaires.
Primary outcome: presence of phobia and avoidance
behaviour
The primary outcome measure is the Fear Questionnaire
(FQ) [20]. This instrument measures severity of fear and
avoidance of phobic stimuli. The FQ is a self-rated ques-
tionnaire adapted for use on the internet and consists of
15 items that measure total phobia and five items that
measure anxiety and depression. Patients are asked to
rate how often they avoid different situations on a scale
of 0 (“I do not avoid this”) to 8 (“I always avoid this”).
Due to the large number of possible specific phobias,
the primary phobia for which the patient seeks treat-
ment is filled out in a single item rather than chosen
from a list.
A total phobia score ranges from 15–120 and is calcu-
lated from three subscales; agoraphobia, blood/injection
phobia and social phobia. A higher score indicates
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sures global phobic distress, or the extent to which pho-
bic symptoms limit the patient’s daily activities, on a
scale of 0 (no phobia) to 8 (extremely limiting or disrup-
tive). The psychometric validity of the FQ has been




The Beck Anxiety Inventory (BAI) [24] is a 21-item self-
report questionnaire which focuses on physiological
manifestations of anxiety, e.g. sweating, trembling and
increased heart rate. Items can be scored from 0–3 for a
total sum score range of 0–63, where higher scores indi-
cate higher levels of self-reported manifestations of anx-
iety. The BAI has been validated for patients with
agoraphobia [25] and other anxiety disorders [26].
Depressive symptoms
The Centre for Epidemiological Studies Depression Scale
(CES-D) [27] is administered as a self-rated question-
naire on the internet. The CES-D consists of 20 items
which are scored from 0–3, the total score can range
from 0–60, where a higher score indicates a higher level
of depressive symptoms. A Dutch version of the CES-D
has been validated in an internet-administrated form
[28].
Quality of life
Health-related quality of life is measured using an
internet-based version of the EuroQol (EQ-5D). The
EQ-5D appears to have sufficient validity [29,30].
Patients report whether they have ‘no problems’, ‘some
problems’ or ‘extreme problems’ on each of five
domains: mobility, self-care, daily activities, pain and dis-
comfort and anxiety/depression. The combination of
items results in 243 distinct health states. This results in
a utility score for each health state that ranges from
death (0) to perfect health (1). The Dutch tariff will be
used to value these health states [31].
Treatment satisfaction
Satisfaction with the internet intervention or the self-
help book is evaluated using the Client Satisfaction
Questionnaire (CSQ-8) [32] which has been validated
for use in a Dutch population [33]. The CSQ-8 has been
adapted to a self-rated internet-administered question-
naire. A total of 8 items can be scored from 1–4, yield-
ing a total range score of 8–32, where a higher score
indicates a higher level of satisfaction with received care.
Several items are added to assess the patient’s satisfac-
tion with the intervention website and coach or the self-help book and, if applicable, why the patient decided to
stop using the book or the website.
Alcohol use
The CAGE questionnaire [34] is a brief screening
measure for alcohol dependence. It has been validated
as being able to establish heavy drinking and/or alcohol
dependence [35]. Although heavy alcohol use is not
among the exclusion criteria, we monitor problematic
alcohol use in the light of the complex relationship be-
tween anxiety disorders and alcohol consumption [36].
Health care utilization and work absenteeism
The iMTA Questionnaire on Costs Associated with Psy-
chiatric Illness (TiC-P) [37] is a structured questionnaire
to measure costs from a societal perspective. Cost cat-
egories that are included are use of medication, health
services and informal care (direct costs), and work ab-
senteeism or and/or reduced work productivity (indirect
costs). The friction cost method will be applied to esti-
mate costs of work absenteeism. Dutch standard costs
will be used to value direct and indirect costs [38].
Data on FTF psychotherapy after intervention or
self-help book
Data on received psychotherapy at the outpatient clinic
will be retrieved post-hoc from the institutions’ elec-
tronic medical records for both groups. Data on the mo-
dality of psychotherapy (e.g. individual CBT, group
therapy) and the number of sessions will be recorded.
Internet-specific data and sundry expenses
Internet usage specifics such as number of logins, total
duration of session, number of modules completed will
be collected on a per-patient basis. Total costs for devel-
opment, maintenance, patient screening, coaching and
sundry expenses are calculated on a per-patient basis
(Table 1).
Sample size
To obtain 90% statistical power with a 2-sided α equal
to 0.05 and assuming a mean standardised effect size
(Cohen’s d) of 0.7 in the intervention group and 0.2 in
the control group, 85 patients are needed for each trial
arm to establish the clinical effect of the internet inter-
vention compared to the waiting list condition (170
patients in total). We assume a dropout rate of 30% dur-
ing one-year follow-up, thus, 244 patients should be
included.
Statistical analyses
Results will be reported on both intention-to-treat and
per-protocol basis. Missing values will be imputed using
multiple imputation, as recent research suggests that this
Table 1 Measurements collected
Baseline/T0 Post-treatment (5 weeks) 3 months 6 months 9 months 12 months
CIDI x
FQ x x x x x
BAI x x x x x
CES-D x x x x x
CSQ x x
EQ5D x x x x x x
TiC-P x x x x x x
Satisfaction x
CAGE x x x x x
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within datasets [39].
Economic outcomes
The mean difference in costs between the control group
and intervention group is calculated, using bootstrapping
to estimate 95% confidence intervals. Incremental cost-
effectiveness ratios (ICERs) will then be calculated by
dividing the difference in costs between the two groups
by the difference in clinical effects. Bootstrapping will
be used to estimate the uncertainty surrounding the
ICERs, which will be graphically represented on cost-
effectiveness planes. Cost-effectiveness acceptability curves
and net monetary benefits will also be calculated. Cost-
effectiveness acceptability curves show the probability that
the intervention is cost-effective in comparison with usual
care for a range of different ceiling ratios, thereby showing
decision uncertainty [40].
Discussion
This study will evaluate the clinical and cost-
effectiveness of offering internet-based guided self-help
for phobic outpatients. Results of internet therapy for
phobias in the general population are encouraging and
implementation in outpatient clinics may be a valuable
addition to existing treatment options. Also, offering of
internet therapy while a patient is waiting for FTF psy-
chotherapy makes efficient use of this time and may
have large benefits for both the patient and the out-
patient clinic in terms of clinical effectiveness, cost-
effectiveness and patient satisfaction.
This study faces a number of challenges. Firstly, it is
imperative that the patients’ therapists assess the needs
of their patients prior to actually starting FTF psycho-
therapy. If the therapist starts the patient on a standard
treatment (e.g. a fixed number of FTF psychotherapy
sessions as prescribed by treatment protocol) regardless
of the skills and knowledge acquired during the internet
intervention, then the addition of the internet interven-
tion would be ineffectual in lowering treatment costs.Secondly, there is considerable variability in the time
patients spend on a waiting list. This varies both be-
tween and within institutions and is influenced by sev-
eral factors such as seasonal changes and peaks or drops
in patient referrals or staff workloads. The direct impli-
cation is that there is some variability in the time be-
tween the end of the guided self-help intervention and
the start of FTF psychotherapy. Patients are allowed to
re-visit the intervention website throughout the remain-
der of the waiting list period. However, they will no
longer be able to communicate with a coach. Since
patients in both the intervention group and the control
group are on the same waiting list, there is no reason to
assume that there is a difference in time spent on the
waiting list between both groups.
Thirdly, attrition from and lack of adherence to
internet-based interventions are debated topics in
internet-based interventions. A recent meta-analysis
found a mean dropout rate of 31% for internet-based
interventions [41]. These dropout figures are often seen
as major drawbacks for the implementation of internet-
based interventions. However, it should be noted that a
meta-analysis of 123 studies found a mean non-usage at-
trition in psychotherapy of 47% [42]. Two main categor-
ies of attrition are patients not or only partially using the
intervention (non-usage attrition) and patients not com-
pleting follow-up assessments (dropout attrition [43]).
Recently, a systematic review of FTF treatments for so-
cial phobia found no link between pre-treatment vari-
ables and non-usage attrition [44]. All aforementioned
studies on attrition have focussed mainly on the general
population instead of a clinical (outpatient) population.
To prevent non-usage and dropout attrition, several
e-mail and telephone reminders are scheduled through-
out this trial. Also, we assume dropout in this outpatient
population to be lower than that of internet interventions
that recruit from the general population.
To our knowledge, this is the first large-scale pragmatic
cost-effectiveness and effectiveness study of an internet-
based intervention for anxiety in outpatient clinics.
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health interventions to the treatment packages offered at
psychiatric outpatient clinics, the findings of this study
will provide valuable information on the additional value
of online treatment of anxiety disorders in general and
phobias in particular.
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